Skip to main content
Premium Trial:

Request an Annual Quote

Waters Sells $200M in Senior Notes, March 16, 2011

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Waters disclosed in a filing with the US Securities and Exchange Commission Wednesday that it has privately placed $200 million of senior notes with institutional investors.

The firm sold three series of notes: $50 million of Series C Senior Notes with a fixed rate interest of 2.5 percent and maturing on March 15, 2016; $100 million of Series D Senior Notes with an interest rate of 3.22 percent and maturing on March 15, 2018; and $50 million of Series E Senior Notes with an interest rate of 3.97 percent and maturing on March 15, 2021.

Waters said that it will use proceeds from the offering to repay other outstanding debt and for general corporate purposes.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.